Back to top

Image: Bigstock

Top Ranked Income Stocks to Buy for June 10th

Read MoreHide Full Article

Here are four stocks with buy rank and strong income characteristics for investors to consider today, June 10th:

Marine Products Corporation (MPX - Free Report) : This manufacturer of recreational fiberglass powerboats has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.6% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 3.4%, compared with the industry average of 0%. Its five-year average dividend yield is 2.2%.

Las Vegas Sands Corp. (LVS - Free Report) : This integrated resorts operator has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 5.5%, compared with the industry average of 0%. Its five-year average dividend yield is 4.7%.

General Mills, Inc. (GIS - Free Report) : This branded consumer foods manufacturer has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.

This Zacks Rank #2 company has a dividend yield of 3.8%, compared with the industry average of 0%. Its five-year average dividend yield is 3.4%.

General Mills, Inc. Dividend Yield (TTM)

General Mills, Inc. Dividend Yield (TTM)

General Mills, Inc. dividend-yield-ttm | General Mills, Inc. Quote

Ethan Allen Interiors Inc. (ETH - Free Report) : This interior design company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6% over the last 60 days.

This Zacks Rank #2 company has a dividend yield of 3.6%, compared with the industry average of 0%. Its five-year average dividend yield is 2.4%.

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>